Manufacturer: British Dragon Pharmaceuticals
Chlorodehydromethyltestosterone is an oral 17-alpha-alkylated steroid with a low androgenic acivity index 0.10-0.15 similar to methenolone and a myotrophic activity index of 0.50. Because of the 4-chloro alteration, chlorodehydromethyltestosterone does not convert into estrogens nor into DHT.
Chlorodehydromethyltestosterone is used in cases of muscle wasting syndrome in HIV patients. Because of it's low androgenic activity chlorodehydromethyltestosterone can be used by woman and does not cause virilization. Chlorodehydromethyltestosterone on low doses does not suppressive on hypothalamic-pituitary axis (HTPA) function.
Dosage and administration:
Adult dose: 10-20mg per day orally
Because of 17-alpha alkylation, moderate reversible increase in liver enzymes has been observed with prolonged use. The effect of chlorodehydromethyltestosterone on cholesterol levels is minimal. Acute overdosage can produce nausea and gastrointestinal upset.
Known or suspected cancer of the prostate or (in men) breast. Pregnancy or breast-feeding. Known cardiovascular disease is a relative contraindication. Chronic liver diseases.